Elisa V Bandera1,2, Kitaw Demissie3, Bo Qin4, Adana A M Llanos4,5, Yong Lin4,5, Baichen Xu4, Karen Pawlish6, Jesse J Plascak4,5, Jennifer Tsui4,7, Angela R Omilian8, William McCann8, Song Yao8, Christine B Ambrosone8, Chi-Chen Hong8. 1. Cancer Prevention and Control Program, Rutgers Cancer Institute of New Jersey, 195 Little Albany St, New Brunswick, NJ, 08903, USA. elisa.bandera@rutgers.edu. 2. Department of Biostatistics and Epidemiology, Rutgers School of Public Health, Piscataway, NJ, USA. elisa.bandera@rutgers.edu. 3. Department of Epidemiology and Biostatistics, School of Public Health, SUNY Downstate Health Sciences University, Brooklyn, NY, USA. 4. Cancer Prevention and Control Program, Rutgers Cancer Institute of New Jersey, 195 Little Albany St, New Brunswick, NJ, 08903, USA. 5. Department of Biostatistics and Epidemiology, Rutgers School of Public Health, Piscataway, NJ, USA. 6. Cancer Epidemiology Services, New Jersey State Cancer Registry, Trenton, NJ, USA. 7. Department of Health Behavior, Society & Policy, Rutgers School of Public Health, Piscataway, NJ, USA. 8. Department of Cancer Prevention and Control, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
Abstract
PURPOSE: The Women's Circle of Health Follow-Up Study is an ongoing longitudinal study of African American/Black breast cancer survivors in New Jersey, specifically designed to evaluate the impact of obesity and related comorbidities on breast cancer survival and health-related quality-of-life in this understudied population. Here, we describe our recruitment and data collection methods and compare characteristics of the overall cohort and the subcohort with follow-up data. METHODS: Newly diagnosed breast cancer cases have been recruited into the study since 2006. Pre-diagnosis data on relevant factors and a saliva sample are collected during an in-person interview within 12 months from diagnosis. In 2013, we began active follow up by recontacting participants annually, including two home visits at approximately 2 and 3 years post-diagnosis, during which blood samples are collected. Mortality outcomes (all-cause and breast cancer-specific mortality) are ascertained through linkage with New Jersey State Cancer Registry files. We expect to assemble a cohort of over 2000 Black breast cancer survivors with at least 800 of them having detailed post-diagnosis data. RESULTS: Distribution of sociodemographic characteristics, body mass index, comorbidities, clinicopathologic characteristics, and treatment modalities were very similar between those in the full cohort and the subset with follow-up data and blood samples. Obesity (> 50%), hypertension (> 58%), and diabetes (22%) were common in this population. CONCLUSIONS AND IMPLICATIONS FOR CANCER SURVIVORS: This ongoing longitudinal study represents a unique resource to better understand breast cancer outcomes, patient-reported symptoms, and health-related quality of life among Black breast cancer survivors.
PURPOSE: The Women's Circle of Health Follow-Up Study is an ongoing longitudinal study of African American/Black breast cancer survivors in New Jersey, specifically designed to evaluate the impact of obesity and related comorbidities on breast cancer survival and health-related quality-of-life in this understudied population. Here, we describe our recruitment and data collection methods and compare characteristics of the overall cohort and the subcohort with follow-up data. METHODS: Newly diagnosed breast cancer cases have been recruited into the study since 2006. Pre-diagnosis data on relevant factors and a saliva sample are collected during an in-person interview within 12 months from diagnosis. In 2013, we began active follow up by recontacting participants annually, including two home visits at approximately 2 and 3 years post-diagnosis, during which blood samples are collected. Mortality outcomes (all-cause and breast cancer-specific mortality) are ascertained through linkage with New Jersey State Cancer Registry files. We expect to assemble a cohort of over 2000 Black breast cancer survivors with at least 800 of them having detailed post-diagnosis data. RESULTS: Distribution of sociodemographic characteristics, body mass index, comorbidities, clinicopathologic characteristics, and treatment modalities were very similar between those in the full cohort and the subset with follow-up data and blood samples. Obesity (> 50%), hypertension (> 58%), and diabetes (22%) were common in this population. CONCLUSIONS AND IMPLICATIONS FOR CANCER SURVIVORS: This ongoing longitudinal study represents a unique resource to better understand breast cancer outcomes, patient-reported symptoms, and health-related quality of life among Black breast cancer survivors.
Entities:
Keywords:
Black women; Breast cancer; Cancer survivors; Comorbidities; Obesity; Quality of life
Authors: Urmila Chandran; Susan E McCann; Gary Zirpoli; Zhihong Gong; Yong Lin; Chi-Chen Hong; Gregory Ciupak; Karen Pawlish; Christine B Ambrosone; Elisa V Bandera Journal: Nutr Cancer Date: 2014-09-29 Impact factor: 2.900
Authors: Kathryn E Weaver; Randi E Foraker; Catherine M Alfano; Julia H Rowland; Neeraj K Arora; Keith M Bellizzi; Ann S Hamilton; Ingrid Oakley-Girvan; Gretchen Keel; Noreen M Aziz Journal: J Cancer Surviv Date: 2013-02-16 Impact factor: 4.442
Authors: C Martin Tammemagi; David Nerenz; Christine Neslund-Dudas; Carolyn Feldkamp; David Nathanson Journal: JAMA Date: 2005-10-12 Impact factor: 56.272
Authors: Keith M Bellizzi; Ashley Wilder Smith; Bryce B Reeve; Catherine M Alfano; Leslie Bernstein; Kathy Meeske; Kathy B Baumgartner; Rachel R Ballard-Barbash Journal: J Health Psychol Date: 2010-05
Authors: Zhihong Gong; Song Yao; Gary Zirpoli; Ting-Yuan David Cheng; Michelle Roberts; Thaer Khoury; Gregory Ciupak; Warren Davis; Karen Pawlish; Lina Jandorf; Dana H Bovbjerg; Elisa V Bandera; Christine B Ambrosone Journal: Int J Cancer Date: 2015-01-29 Impact factor: 7.396
Authors: Christine B Ambrosone; Gregory L Ciupak; Elisa V Bandera; Lina Jandorf; Dana H Bovbjerg; Gary Zirpoli; Karen Pawlish; James Godbold; Helena Furberg; Anne Fatone; Heiddis Valdimarsdottir; Song Yao; Yulin Li; Helena Hwang; Warren Davis; Michelle Roberts; Lara Sucheston; Kitaw Demissie; Kandace L Amend; Paul Tartter; James Reilly; Benjamin W Pace; Thomas Rohan; Joseph Sparano; George Raptis; Maria Castaldi; Alison Estabrook; Sheldon Feldman; Christina Weltz; Margaret Kemeny Journal: J Oncol Date: 2009-10-25 Impact factor: 4.375
Authors: Rohan Rao; Jasmine A McDonald; Emily S Barrett; Patricia Greenberg; Dede K Teteh; Susanne B Montgomery; Bo Qin; Yong Lin; Chi-Chen Hong; Christine B Ambrosone; Kitaw Demissie; Elisa V Bandera; Adana A M Llanos Journal: Environ Res Date: 2021-08-11 Impact factor: 6.498
Authors: Susana Echeverri-Herrera; Molly A Nowels; Bo Qin; Irina B Grafova; Nur Zeinomar; Dhanya Chanumolu; Paul R Duberstein; Elisa V Bandera Journal: Support Care Cancer Date: 2022-10-07 Impact factor: 3.359
Authors: Jesse J Plascak; Stephen J Mooney; Mario Schootman; Andrew G Rundle; Adana A M Llanos; Bo Qin; Chi-Chen Hong; Kitaw Demissie; Elisa V Bandera; Xinyi Xu Journal: Spat Spatiotemporal Epidemiol Date: 2022-03-24
Authors: Cathleen Y Xing; Michelle Doose; Bo Qin; Yong Lin; Tiffany L Carson; Jesse J Plascak; Kitaw Demissie; Chi-Chen Hong; Elisa V Bandera; Adana A M Llanos Journal: Breast Cancer Res Treat Date: 2020-09-10 Impact factor: 4.872
Authors: Michelle Doose; Janeth I Sanchez; Joel C Cantor; Jesse J Plascak; Michael B Steinberg; Chi-Chen Hong; Kitaw Demissie; Elisa V Bandera; Jennifer Tsui Journal: JCO Oncol Pract Date: 2021-05
Authors: Michelle Doose; Jennifer Tsui; Michael B Steinberg; Cathleen Y Xing; Yong Lin; Joel C Cantor; Chi-Chen Hong; Kitaw Demissie; Elisa V Bandera Journal: Cancer Causes Control Date: 2021-01-06 Impact factor: 2.506
Authors: Jesse J Plascak; Adana A M Llanos; Bo Qin; Laxmi Chavali; Yong Lin; Karen S Pawlish; Noreen Goldman; Chi-Chen Hong; Kitaw Demissie; Elisa V Bandera Journal: Health Place Date: 2020-12-28 Impact factor: 4.078
Authors: Elisa V Bandera; Bo Qin; Yong Lin; Nur Zeinomar; Baichen Xu; Dhanya Chanumolu; Adana A M Llanos; Coral O Omene; Karen S Pawlish; Christine B Ambrosone; Kitaw Demissie; Chi-Chen Hong Journal: JAMA Oncol Date: 2021-06-04 Impact factor: 33.006
Authors: Brian D Gonzalez; Sarah L Eisel; Bo Qin; Adana A M Llanos; Josée Savard; Aasha I Hoogland; Heather Jim; Yong Lin; Kitaw Demissie; Chi-Chen Hong; Elisa V Bandera Journal: Support Care Cancer Date: 2020-09-29 Impact factor: 3.603
Authors: Jeanne M Ferrante; Aaron Lulla; Julie D Williamson; Katie A Devine; Pamela Ohman-Strickland; Elisa V Bandera Journal: Am J Health Promot Date: 2021-08-04